- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Serum S100B protein as a marker of severity in Covid-19 patients ; volume:10 ; number:1 ; day:29 ; month:10 ; year:2020 ; pages:1-8 ; date:12.2020
Scientific reports ; 10, Heft 1 (29.10.2020), 1-8, 12.2020
- Urheber
-
Aceti, Antonio
Margarucci, Lory Marika
Scaramucci, Elena
Orsini, Massimiliano
Salerno, Gerardo
Di Sante, Gabriele
Gianfranceschi, Gianluca
Di Liddo, Rosa
Valeriani, Federica
Ria, Francesco
Simmaco, Maurizio
Parnigotto, Pier Paolo
Vitali, Matteo
Romano Spica, Vincenzo
Michetti, Fabrizio
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-020-75618-0
- URN
-
urn:nbn:de:101:1-2020120920124271675284
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Aceti, Antonio
- Margarucci, Lory Marika
- Scaramucci, Elena
- Orsini, Massimiliano
- Salerno, Gerardo
- Di Sante, Gabriele
- Gianfranceschi, Gianluca
- Di Liddo, Rosa
- Valeriani, Federica
- Ria, Francesco
- Simmaco, Maurizio
- Parnigotto, Pier Paolo
- Vitali, Matteo
- Romano Spica, Vincenzo
- Michetti, Fabrizio
- SpringerLink (Online service)
Ähnliche Objekte (12)
S100β as a serum marker in endocrine resistant breast cancer
Association of S100B polymorphisms and serum S100B with risk of ischemic stroke in a Chinese population
Detection the severity of organophosphate intoxication using sensitive serum biomarkers S100B and amyloid β (Aβ) in Egyptian subjects
Kinetic modelling of serum S100b after traumatic brain injury
Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome
Plasma markers of COVID-19 severity: a pilot study
Neuronenspezifische Enolase und S100B im Serum von Patienten mit Hirnblutung
Serum levels of S100B and NSE proteins in Alzheimer's disease patients
Association of serum uric acid levels with COVID-19 severity
Serum uric acid, disease severity and outcomes in COVID-19
S100B als Marker für Lewy-Körper-Erkrankungen : Eine Fall-Kontroll-Studie mit Bestimmung von Einzelbasen-Polymorphismen und Serum- und Liquorwerten
Serum S100B levels after meningioma surgery: A comparison of two laboratory assays
S100β as a serum marker in endocrine resistant breast cancer
Association of S100B polymorphisms and serum S100B with risk of ischemic stroke in a Chinese population
Detection the severity of organophosphate intoxication using sensitive serum biomarkers S100B and amyloid β (Aβ) in Egyptian subjects
Kinetic modelling of serum S100b after traumatic brain injury
Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome
Plasma markers of COVID-19 severity: a pilot study
Neuronenspezifische Enolase und S100B im Serum von Patienten mit Hirnblutung
Serum levels of S100B and NSE proteins in Alzheimer's disease patients
Association of serum uric acid levels with COVID-19 severity
Serum uric acid, disease severity and outcomes in COVID-19
S100B als Marker für Lewy-Körper-Erkrankungen : Eine Fall-Kontroll-Studie mit Bestimmung von Einzelbasen-Polymorphismen und Serum- und Liquorwerten
Serum S100B levels after meningioma surgery: A comparison of two laboratory assays
S100β as a serum marker in endocrine resistant breast cancer
Association of S100B polymorphisms and serum S100B with risk of ischemic stroke in a Chinese population
Detection the severity of organophosphate intoxication using sensitive serum biomarkers S100B and amyloid β (Aβ) in Egyptian subjects
Kinetic modelling of serum S100b after traumatic brain injury
Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome
Plasma markers of COVID-19 severity: a pilot study
Neuronenspezifische Enolase und S100B im Serum von Patienten mit Hirnblutung
Serum levels of S100B and NSE proteins in Alzheimer's disease patients
Association of serum uric acid levels with COVID-19 severity
Serum uric acid, disease severity and outcomes in COVID-19
S100B als Marker für Lewy-Körper-Erkrankungen : Eine Fall-Kontroll-Studie mit Bestimmung von Einzelbasen-Polymorphismen und Serum- und Liquorwerten